Emcure Pharmaceuticals, backed by Namita Thapar, made a remarkable debut on the Indian stock exchanges on Wednesday, July 10. The shares were listed at ₹1,325.05 apiece on the BSE, reflecting a 31.45 percent premium over the issue price of ₹1,008. Following the listing, Emcure Pharma’s shares climbed further to ₹1,384, […]
Emcure Pharma IPO
Emcure Pharma IPO: The bidding for the initial public offering (IPO) of Emcure Pharmaceuticals Limited concluded on Friday last week, with the public issue worth ₹1,952.03 crore receiving a robust response from the Indian primary market investors. The Emcure Pharma IPO subscription status reveals that the public issue was oversubscribed […]
Stock market investors have shown a powerful response to Emcure Pharmaceuticals Limited’s initial public offering (IPO), with all three categories—Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Investors—displaying robust bidding figures on the third day of the offering. According to data from the Bombay Stock Exchange (BSE) website, the […]
Investor response to Emcure Pharmaceuticals IPO on the second bidding day was overwhelmingly positive, with the market as a whole being robust. The offering has flowed quite well thanks to the enthusiasm shown by non-institutional investors, individual investors, and qualified institutional buyers. The Pune-based company Emcure Pharmaceuticals is involved in […]
Emcure Pharmaceuticals initial public offerings (IPO), which opened for subscription on Wednesday, was fully subscribed by the later half of the first day of bidding, driven by strong demand from non-institutional investors. The issue has been subscribed 1.22 times in the retail category and 1.92 times in the NII portion, […]
Emcure Pharmaceuticals IPO subscription status: The initial public offering of Emcure Pharmaceuticals Ltd kickstarts for subscriptions today (Wednesday, July 3). At an upper price range of ₹1,008 per equity share, Emcure Pharmaceuticals Ltd picked up ₹582 crore from 48 anchor investors, on Tuesday, July 2. Bain Capital-backed Emcure Pharmaceuticals IPO, […]
The Pune-based Emcure Pharma is all set to launch its initial public offerings (IPO) next week. The IPO will open for subscription on July 3 and will close on July 5. The shares of Emcure Pharma IPO is trading at a premium of ₹255 in the grey market premium (GMP) […]